Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study
ConclusionAntiplatelet prescribing and suboptimal warfarin management remain common in Chinese patients with AF at high risk of stroke. DOAC use may be associated with a lower risk of ischemic stroke and all-cause mortality when compared with antiplatelets and with a lower risk of ICH when compared with warfarin.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Atrial Fibrillation | Bleeding | China Health | Coumadin | Drugs & Pharmacology | Electronic Health Records (EHR) | Gastroenterology | Hemorrhagic Stroke | Hong Kong Health | Ischemic Stroke | Stroke | Study | Warfarin